nach oben

Current Cardiology Reports

Erschienen in:

26.01.2022 | Congenital Heart Disease (RA Krasuski and G Fleming, Section Editors)

Anesthetic Management in Adults with Congenital Heart Disease

verfasst von: Jon S. Andrews, Nazish K. Hashmi

Erschienen in: Current Cardiology Reports | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Adults with congenital heart disease (ACHD) are a complex and growing population that presents numerous challenges for anesthetic management. This review summarizes special considerations for anesthetic management in ACHD.

Recent Findings

The adult patient with congenital heart disease may require anesthetic care for multiple surgeries and interventions throughout their lifetime. The cardiac and extracardiac manifestations of ACHD have important perioperative implications that affect anesthetic management. Recent American Heart Association/American College of Cardiology and European Society of Cardiology guidelines endorse a multidisciplinary, team-based approach to care. The cardiac anesthesiologist, endorsed as part of this multidisciplinary team, must have a thorough understanding of congenital heart disease pathophysiology and common extra-cardiac manifestations of ACHD.

Summary

Safe anesthetic management in adult congenital heart disease should incorporate a multi-disciplinary approach to patient care. Anesthesiologists and centers with special expertise in ACHD care should be utilized or consulted whenever possible.

Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900. https://doi.org/10.1016/s0735-1097(02)01886-7.CrossRefPubMed

Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–56. https://doi.org/10.1161/CIRCULATIONAHA.113.008396.CrossRefPubMed

Lei Lei E, Ladha K, Mueller B, Roche L, Rao V, Hickey E, et al. Noncardiac determinants of death and intensive care morbidity in adult congenital heart disease surgery. J Thorac Cardiovasc Surg. 2020;159(6):2407–15 e2. https://doi.org/10.1016/j.jtcvs.2019.07.106.

Karangelis D, Mazine A, Narsupalli S, Mendis S, Veldtman G, Nikolaidis N. Morbidity after cardiac surgery in patients with adult congenital heart disease in comparison with acquired disease. Heart Lung Circ. 2018;27(6):739–44. https://doi.org/10.1016/j.hlc.2017.05.133.CrossRefPubMed

Mackie AS, Ionescu-Ittu R, Therrien J, Pilote L, Abrahamowicz M, Marelli AJ. Children and adults with congenital heart disease lost to follow-up: who and when? Circulation. 2009;120(4):302–9. https://doi.org/10.1161/CIRCULATIONAHA.108.839464.CrossRefPubMed

Gerardin J, Raskind-Hood C, Rodriguez FH 3rd, Hoffman T, Kalogeropoulos A, Hogue C, et al. Lost in the system? Transfer to adult congenital heart disease care-challenges and solutions. Congenit Heart Dis. 2019;14(4):541–8. https://doi.org/10.1111/chd.12780.CrossRefPubMedPubMedCentral

Fernandes SM, Marelli A, Hile DM, Daniels CJ. Access and delivery of adult congenital heart disease care in the United States: quality-driven team-based care. Cardiol Clin. 2020;38(3):295–304. https://doi.org/10.1016/j.ccl.2020.04.012.CrossRefPubMed

O’Brien SM, Clarke DR, Jacobs JP, Jacobs ML, Lacour-Gayet FG, Pizarro C, et al. An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg. 2009;138(5):1139–53. https://doi.org/10.1016/j.jtcvs.2009.03.071.CrossRefPubMed

•• Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Circulation 2019;139(14):e698–e800. https://doi.org/10.1161/CIR.0000000000000603. Updated guideline which includes specific recommendations for specialized ACHD centers, including utilization of anesthesiologists with ACHD expertise.

10.

Cho MY, Weidenbach M, Sinzobahamvya N, Grafe K, Murin P, Berger F, et al. Adult congenital open-heart surgery: emergence of a new mortality score. Eur J Cardiothorac Surg. 2020;58(1):171–6. https://doi.org/10.1093/ejcts/ezaa024.CrossRefPubMed

11.

Gaeta SA, Ward C, Krasuski RA. Extra-cardiac manifestations of adult congenital heart disease. Trends Cardiovasc Med. 2016;26(7):627–36. https://doi.org/10.1016/j.tcm.2016.04.004.CrossRefPubMed

12.

Gurvitz M, Ionescu-Ittu R, Guo L, Eisenberg MJ, Abrahamowicz M, Pilote L, et al. Prevalence of cancer in adults with congenital heart disease compared with the general population. Am J Cardiol. 2016;118(11):1742–50. https://doi.org/10.1016/j.amjcard.2016.08.057.CrossRefPubMed

13.

Deen JF, Krieger EV, Slee AE, Arslan A, Arterburn D, Stout KK, et al. Metabolic syndrome in adults with congenital heart disease. J Am Heart Assoc. 2016;5(2). https://doi.org/10.1161/JAHA.114.001132.

14.

Baehner T, Ellerkmann RK. Anesthesia in adults with congenital heart disease. Curr Opin Anaesthesiol. 2017;30(3):418–25. https://doi.org/10.1097/ACO.0000000000000468.CrossRefPubMed

15.

Budts W, Roos-Hesselink J, Radle-Hurst T, Eicken A, McDonagh TA, Lambrinou E, et al. Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2016;37(18):1419–27. https://doi.org/10.1093/eurheartj/ehv741.CrossRefPubMedPubMedCentral

16.

Ramamoorthy C, Haberkern CM, Bhananker SM, Domino KB, Posner KL, Campos JS, et al. Anesthesia-related cardiac arrest in children with heart disease: data from the Pediatric Perioperative Cardiac Arrest (POCA) registry. Anesth Analg. 2010;110(5):1376–82. https://doi.org/10.1213/ANE.0b013e3181c9f927.CrossRefPubMed

17.

Baggen VJ, van den Bosch AE, Eindhoven JA, Schut AW, Cuypers JA, Witsenburg M, et al. Prognostic value of N-Terminal Pro-B-type natriuretic peptide, troponin-T, and growth-differentiation factor 15 in adult congenital heart disease. Circulation. 2017;135(3):264–79. https://doi.org/10.1161/CIRCULATIONAHA.116.023255.CrossRefPubMed

18.

van den Bosch E, Bossers SSM, Kamphuis VP, Boersma E, Roos-Hesselink JW, Breur J, et al. Associations between blood biomarkers, cardiac function, and adverse outcome in a young Fontan cohort. J Am Heart Assoc. 2021;10(5): e015022. https://doi.org/10.1161/JAHA.119.015022.CrossRefPubMedPubMedCentral

19.

Menachem JN, Schlendorf KH, Mazurek JA, Bichell DP, Brinkley DM, Frischhertz BP, et al. Advanced heart failure in adults with congenital heart disease. JACC Heart Fail. 2020;8(2):87–99. https://doi.org/10.1016/j.jchf.2019.08.012.CrossRefPubMed

20.

Fishberger SB, Wernovsky G, Gentles TL, Gauvreau K, Burnett J, Mayer JE Jr, et al. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg. 1997;113(1):80–6.CrossRefPubMed

21.

Flinn CJ, Wolff GS, Dick M 2nd, Campbell RM, Borkat G, Casta A, et al. Cardiac rhythm after the Mustard operation for complete transposition of the great arteries. N Engl J Med. 1984;310(25):1635–8. https://doi.org/10.1056/NEJM198406213102504.CrossRefPubMed

22.

Ghai A, Harris L, Harrison DA, Webb GD, Siu SC. Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation. J Am Coll Cardiol. 2001;37(2):585–92.CrossRefPubMed

23.

Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340(11):839–46. https://doi.org/10.1056/NEJM199903183401103.CrossRefPubMed

24.

Khairy P. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease. Heart. 2016;102(21):1703–9. https://doi.org/10.1136/heartjnl-2015-309069.CrossRefPubMed

25.

Cardiac Implantable Electronic Device Management [corrected]. Anesthesiology. 2020;132(2):225–52. https://doi.org/10.1097/ALN.0000000000002821.

26.

Bernier ML, Jacob AI, Collaco JM, McGrath-Morrow SA, Romer LH, Unegbu CC. Perioperative events in children with pulmonary hypertension undergoing non-cardiac procedures. Pulm Circ. 2018;8(1):2045893217738143. https://doi.org/10.1177/2045893217738143.CrossRefPubMed

27.

Dimopoulos K, Peset A, Gatzoulis MA. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol. 2008;129(2):163–71. https://doi.org/10.1016/j.ijcard.2008.02.004.CrossRefPubMed

28.

Kempny A, Hjortshoj CS, Gu H, Li W, Opotowsky AR, Landzberg MJ, et al. Predictors of Death in contemporary adult patients with eisenmenger syndrome: a multicenter study. Circulation. 2017;135(15):1432–40. https://doi.org/10.1161/CIRCULATIONAHA.116.023033.CrossRefPubMed

29.

Latham GJ, Yung D. Current understanding and perioperative management of pediatric pulmonary hypertension. Paediatr Anaesth. 2019;29(5):441–56. https://doi.org/10.1111/pan.13542.CrossRefPubMed

30.

Sabato LA, Salerno DM, Moretz JD, Jennings DL. Inhaled pulmonary vasodilator therapy for management of right ventricular dysfunction after left ventricular assist device placement and cardiac transplantation. Pharmacotherapy. 2017;37(8):944–55. https://doi.org/10.1002/phar.1959.CrossRefPubMed

31.

Cannesson M, Collange V, Lehot JJ. Anesthesia in adult patients with congenital heart disease. Curr Opin Anaesthesiol. 2009;22(1):88–94. https://doi.org/10.1097/ACO.0b013e32831c83cb.CrossRefPubMed

32.

Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol. 2006;98(2):254–8. https://doi.org/10.1016/j.amjcard.2006.01.083.CrossRefPubMed

33.

Waldow HC, Westhoff-Bleck M, Widera C, Templin C, von Depka M. Acquired von Willebrand syndrome in adult patients with congenital heart disease. Int J Cardiol. 2014;176(3):739–45. https://doi.org/10.1016/j.ijcard.2014.07.104.CrossRefPubMed

34.

Dimopoulos K, Diller GP, Giannakoulas G, Petraco R, Chamaidi A, Karaoli E, et al. Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol. 2009;54(22):2093–100. https://doi.org/10.1016/j.jacc.2009.06.050.CrossRefPubMed

35.

Desborough MJ, Oakland KA, Landoni G, Crivellari M, Doree C, Estcourt LJ, et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2017;15(2):263–72. https://doi.org/10.1111/jth.13576.CrossRefPubMed

36.

Machovec KA, Jooste EH. Pediatric transfusion algorithms: coming to a cardiac operating room near you. J Cardiothorac Vasc Anesth. 2019;33(7):2017–29. https://doi.org/10.1053/j.jvca.2018.12.008.CrossRefPubMed

37.

Mandalenakis Z, Rosengren A, Lappas G, Eriksson P, Hansson PO, Dellborg M. Ischemic stroke in children and young adults with congenital heart disease. J Am Heart Assoc. 2016;5(2). https://doi.org/10.1161/JAHA.115.003071.

38.

Hoffmann A, Chockalingam P, Balint OH, Dadashev A, Dimopoulos K, Engel R, et al. Cerebrovascular accidents in adult patients with congenital heart disease. Heart. 2010;96(15):1223–6. https://doi.org/10.1136/hrt.2010.196147.CrossRefPubMed

39.

Lanz J, Brophy JM, Therrien J, Kaouache M, Guo L, Marelli AJ. Stroke in adults with congenital heart disease: incidence, cumulative risk, and predictors. Circulation. 2015;132(25):2385–94. https://doi.org/10.1161/CIRCULATIONAHA.115.011241.CrossRefPubMed

40.

Heidendael JF, Bokma JP, de Groot JR, Koolbergen DR, Mulder BJ, Bouma BJ. Weighing the risks: thrombotic and bleeding events in adults with atrial arrhythmias and congenital heart disease. Int J Cardiol. 2015;186:315–20. https://doi.org/10.1016/j.ijcard.2015.02.024.CrossRefPubMed

41.

Idorn L, Jensen AS, Juul K, Reimers JI, Johansson PI, Sorensen KE, et al. Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology. Pediatr Cardiol. 2013;34(2):262–72. https://doi.org/10.1007/s00246-012-0431-4.CrossRefPubMed

42.

Egbe AC, Connolly HM, Niaz T, Yogeswaran V, Taggart NW, Qureshi MY, et al. Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation. Am Heart J. 2017;183:10–7. https://doi.org/10.1016/j.ahj.2016.09.014.CrossRefPubMed

43.

Egbe AC, Connolly HM, McLeod CJ, Ammash NM, Niaz T, Yogeswaran V, et al. Thrombotic and embolic complications associated with atrial arrhythmia after fontan operation: role of prophylactic therapy. J Am Coll Cardiol. 2016;68(12):1312–9. https://doi.org/10.1016/j.jacc.2016.06.056.CrossRefPubMed

44.

Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL. Thrombus formation after the Fontan operation. Ann Thorac Surg. 2001;71(6):1990–4. https://doi.org/10.1016/s0003-4975(01)02472-9.CrossRefPubMed

45.

Zabala LM, Guzzetta NA. Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations. Paediatr Anaesth. 2015;25(10):981–9. https://doi.org/10.1111/pan.12705.CrossRefPubMed

46.

Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117(18):2320–8. https://doi.org/10.1161/CIRCULATIONAHA.107.734921.CrossRefPubMed

47.

Morgan C, Al-Aklabi M, Garcia GG. Chronic kidney disease in congenital heart disease patients: a narrative review of evidence. Can J Kidney Health Dis. 2015;2:27. https://doi.org/10.1186/s40697-015-0063-8.CrossRefPubMedPubMedCentral

48.

Fuhrman DY, Nguyen L, Joyce EL, Priyanka P, Kellum JA. Outcomes of adults with congenital heart disease that experience acute kidney injury in the intensive care unit. Cardiol Young. 2021;31(2):274–8. https://doi.org/10.1017/S1047951120003923.CrossRefPubMed

49.

Elahi MM, Lim MY, Joseph RN, Dhannapuneni RR, Spyt TJ. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg. 2004;26(5):1027–31. https://doi.org/10.1016/j.ejcts.2004.07.039.CrossRefPubMed

50.

Lammers AE, Bauer LJ, Diller GP, Helm PC, Abdul-Khaliq H, Bauer UMM, et al. Pulmonary hypertension after shunt closure in patients with simple congenital heart defects. Int J Cardiol. 2020;308:28–32. https://doi.org/10.1016/j.ijcard.2019.12.070.CrossRefPubMed

51.

Saha P, Potiny P, Rigdon J, Morello M, Tcheandjieu C, Romfh A, et al. Substantial cardiovascular morbidity in adults with lower-complexity congenital heart disease. Circulation. 2019;139(16):1889–99. https://doi.org/10.1161/CIRCULATIONAHA.118.037064.CrossRefPubMedPubMedCentral

52.

Wise-Faberowski L, Irvin M, Sidell DR, Rajashekara S, Asija R, Chan FP, et al. Assessment of airway abnormalities in patients with tetralogy of Fallot, pulmonary atresia, and major aortopulmonary collaterals. Cardiol Young. 2019;29(5):610–4. https://doi.org/10.1017/S1047951119000301.CrossRefPubMed

53.

Foz C, Peyton J, Staffa SJ, Kovatsis P, Park R, DiNardo JA, et al. Airway abnormalities in patients with congenital heart disease: incidence and associated factors. J Cardiothorac Vasc Anesth. 2021;35(1):139–44. https://doi.org/10.1053/j.jvca.2020.07.086.CrossRefPubMed

54.

Cui Y, Li G, Cao R, Luan L, Kla KM. The effect of perioperative anesthetics for prevention of postoperative delirium on general anesthesia: a network meta-analysis. J Clin Anesth. 2020;59:89–98. https://doi.org/10.1016/j.jclinane.2019.06.028.CrossRefPubMed

55.

Bennett JM, Ehrenfeld JM, Markham L, Eagle SS. Anesthetic management and outcomes for patients with pulmonary hypertension and intracardiac shunts and Eisenmenger syndrome: a review of institutional experience. J Clin Anesth. 2014;26(4):286–93. https://doi.org/10.1016/j.jclinane.2013.11.022.CrossRefPubMed

56.

Montealegre-Gallegos M, Bortman J, Chaudhry D, Mahmood F. Adult congenital heart defects: how many is too many? J Cardiothorac Vasc Anesth. 2016;30(3):848–51. https://doi.org/10.1053/j.jvca.2015.08.010.CrossRefPubMed

57.

Tutarel O, Alonso-Gonzalez R, Montanaro C, Schiff R, Uribarri A, Kempny A, et al. Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart. 2018;104(2):161–5. https://doi.org/10.1136/heartjnl-2017-311650.CrossRefPubMed

58.

Ono M, Georgiev S, Burri M, Mayr B, Cleuziou J, Strbad M, et al. Early extubation improves outcome following extracardiac total cavopulmonary connection. Interact Cardiovasc Thorac Surg. 2019;29(1):85–92. https://doi.org/10.1093/icvts/ivz010.CrossRefPubMed

59.

Weismann CG, Yang SF, Bodian C, Hollinger I, Nguyen K, Mittnacht AJ. Early extubation in adults undergoing surgery for congenital heart disease. J Cardiothorac Vasc Anesth. 2012;26(5):773–6. https://doi.org/10.1053/j.jvca.2012.04.009.CrossRefPubMed

60.

Kim KM, Kwak JG, Shin BC, Kim ER, Lee JH, Kim EH, et al. Early experiences with ultra-fast-track extubation after surgery for congenital heart disease at a single center. Korean J Thorac Cardiovasc Surg. 2018;51(4):247–53. https://doi.org/10.5090/kjtcs.2018.51.4.247.CrossRefPubMedPubMedCentral

61.

• Bianchi P, Constantine A, Costola G, Mele S, Shore D, Dimopoulos K, et al. Ultra-fast-track extubation in adult congenital heart surgery. J Am Heart Assoc. 2021;10(11):e020201. https://doi.org/10.1161/JAHA.120.020201. This retrospective study in a large population of patients found that ultra-fast-track extubation in the operating room was associated with a low reintubation rate, decreased use of vasopressors, and more rapid discharge from ICU.

62.

Mylotte D, Pilote L, Ionescu-Ittu R, Abrahamowicz M, Khairy P, Therrien J, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129(18):1804–12. https://doi.org/10.1161/CIRCULATIONAHA.113.005817.CrossRefPubMed

63.

ACHA ACHD Accreditation Program Criteria. https://www.achaheart.org/media/2637/achaachdprogramcriteria2020.pdf Accessed August 1, 2021.

64.

Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645. https://doi.org/10.1093/eurheartj/ehaa554.CrossRefPubMed

65.

Maxwell BG, Posner KL, Wong JK, Oakes DA, Kelly NE, Domino KB, et al. Factors contributing to adverse perioperative events in adults with congenital heart disease: a structured analysis of cases from the Closed Claims Project. Congenit Heart Dis. 2015;10(1):21–9. https://doi.org/10.1111/chd.12188.CrossRefPubMed

66.

Maxwell BG, Williams GD, Ramamoorthy C. Knowledge and attitudes of anesthesia providers about noncardiac surgery in adults with congenital heart disease. Congenit Heart Dis. 2014;9(1):45–53. https://doi.org/10.1111/chd.12076.CrossRefPubMed

67.

Ezzeddine FM, Moe T, Ephrem G, Kay WA. Do we have the ACHD physician resources we need to care for the burgeoning ACHD population? Congenit Heart Dis. 2019;14(4):511–6. https://doi.org/10.1111/chd.12771.CrossRefPubMed

68.

Diller GP, Orwat S, Lammers AE, Radke RM, De-Torres-Alba F, Schmidt R, et al. Lack of specialist care is associated with increased morbidity and mortality in adult congenital heart disease: a population-based study. Eur Heart J. 2021. https://doi.org/10.1093/eurheartj/ehab422.CrossRefPubMed

69.

Erdoes G, Schindler E, Koster A, Schulte-Uentrop L, Dossow V, von Nasr VG. When highly specialized anesthesia care is needed: comments on the, 2020 ESC Guidelines for Management of Adult Congenital Heart Disease. J Cardiothorac Vasc Anesth 2021. https://doi.org/10.1053/j.jvca.2021.04.045

Titel: Anesthetic Management in Adults with Congenital Heart Disease
verfasst von: Jon S. Andrews
Nazish K. Hashmi
Publikationsdatum: 26.01.2022
Verlag: Springer US
Erschienen in: Current Cardiology Reports / Ausgabe 3/2022
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-022-01639-y

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Anesthetic Management in Adults with Congenital Heart Disease

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

The New Role of Telehealth in Contemporary Medicine

Role of Cardiac Fibroblasts in Cardiac Injury and Repair

Revascularization Strategies in Patients with Diabetes and Acute Coronary Syndromes

Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention

Team-Based Care in Patients with Chronic Limb-Threatening Ischemia

Burden and Impact of Arrhythmias in Repaired Tetralogy of Fallot

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie